Anti-Fungal Drugs Market 2020 By Industry Size Estimation, Industry Share

0
0

The global anti-fungal drugs market size is likely to reach USD 13.17 billion by 2027 on account of the increasing prevalence of skin infections worldwide. Mycosis or fungal infection is a skin disease caused by a group of spore-producing organisms living and feeding on the human skin. When untreated, they lead to skin issues such as rashes, athlete’s foot, yeast infection, ringworm, nail fungus, bumps, and others. According to a recently published report by Fortune Business Insights titled, “Anti-Fungal Drugs Market Size, Share & Industry Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Others), and Regional Forecast, 2020-2027,” the market value was USD 10.24 billion in 2019, and will exhibit a CAGR of 3.3% between 2020 and 2027.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/antifungal-drugs-market-101188

Detailed Table of Content:

 

  1. Introduction

1.1.    Research Scope

1.2.    Market Segmentation

1.3.    Research Methodology

1.4.    Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.    Market Drivers

3.2.    Market Restraints

3.3.    Market Opportunities

  1. Key Insights

4.1.    Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)

4.2.    Prevalence of Fungal Infections

4.3.    Pipeline Analysis

4.4.    New Product Launches

  1. Global Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027

5.1.    Key Findings / Summary

5.2.    Market Analysis, Insights and Forecast – By Drug Type

5.2.1. Azoles

5.2.2. Echinocandins

5.2.3. Polyenes

5.2.4. Allylamines

5.3.    Market Analysis, Insights and Forecast – By Indication

5.3.1. Dermatophytosis

5.3.2. Candidiasis

5.3.3. Aspergillosis

5.3.4. Others

5.4.    Market Analysis, Insights and Forecast – By Route of Administration

5.4.1. Oral

5.4.2. Topical

5.4.3. Parenteral

5.5.    Market Analysis, Insights and Forecast – By Distribution Channel

5.5.1. Hospitals Pharmacies

5.5.2. Retail Pharmacies & Drug Stores

5.5.3. Online Pharmacies

5.6.    Market Analysis, Insights and Forecast – By Region

5.6.1. North America

5.6.2. Europe

5.6.3. Asia pacific

5.6.4. Latin America

5.6.5. Middle East & Africa

  1. North America Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027

6.1.    Key Findings / Summary

6.2.    Market Analysis – By Drug Type

6.2.1. Azoles

6.2.2. Echinocandins

6.2.3. Polyenes

6.2.4. Allylamines

6.3.    Market Analysis – By Indication

6.3.1. Dermatophytosis

6.3.2. Candidiasis

6.3.3. Aspergillosis

6.3.4. Others

6.4.    Market Analysis – By Route of Administration

6.4.1. Oral

6.4.2. Topical

6.4.3. Parenteral

6.5.    Market Analysis – By Distribution Channel

6.5.1. Hospitals Pharmacies

6.5.2. Retail Pharmacies & Drug Stores

6.5.3. Online Pharmacies

6.6.    Market Analysis – By Country

6.6.1. U.S.

6.6.2. Canada

  1. Europe Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027

7.1.    Key Findings / Summary

7.2.    Market Analysis – By Drug Type

7.2.1. Azoles

7.2.2. Echinocandins

7.2.3. Polyenes

7.2.4. Allylamines

7.3.    Market Analysis – By Indication

7.3.1. Dermatophytosis

7.3.2. Candidiasis

7.3.3. Aspergillosis

7.3.4. Others

7.4.    Market Analysis – By Route of Administration

7.4.1. Oral

7.4.2. Topical

7.4.3. Parenteral

7.5.    Market Analysis – By Distribution Channel

7.5.1. Hospitals Pharmacies

7.5.2. Retail Pharmacies & Drug Stores

7.5.3. Online Pharmacies

7.6.    Market Analysis – By Country/ sub-region

7.6.1. U.K.

7.6.2. Germany

7.6.3. France

7.6.4. Spain

7.6.5. Italy

7.6.6. Scandinavia

7.6.7. Rest of Europe

  1. Asia pacific Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027

8.1.    Key Findings / Summary

8.2.    Market Analysis – By Drug Type

8.2.1. Azoles

8.2.2. Echinocandins

8.2.3. Polyenes

8.2.4. Allylamines

8.3.    Market Analysis – By Indication

8.3.1. Dermatophytosis

8.3.2. Candidiasis

8.3.3. Aspergillosis

8.3.4. Others

8.4.    Market Analysis – By Route of Administration

8.4.1. Oral

8.4.2. Topical

8.4.3. Parenteral

8.5.    Market Analysis – By Distribution Channel

8.5.1. Hospitals Pharmacies

8.5.2. Retail Pharmacies & Drug Stores

8.5.3. Online Pharmacies

8.6.    Market Analysis – By Country/ sub-region

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. Australia

8.6.5. Southeast Asia

8.6.6. Rest of Asia Pacific

  1. Latin America Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027

9.1.    Key Findings / Summary

9.2.    Market Analysis – By Drug Type

9.2.1. Azoles

9.2.2. Echinocandins

9.2.3. Polyenes

9.2.4. Allylamines

9.3.    Market Analysis – By Indication

9.3.1. Dermatophytosis

9.3.2. Candidiasis

9.3.3. Aspergillosis

9.3.4. Others

9.4.    Market Analysis – By Route of Administration

9.4.1. Oral

9.4.2. Topical

9.4.3. Parenteral

9.5.    Market Analysis – By Distribution Channel

9.5.1. Hospitals Pharmacies

9.5.2. Retail Pharmacies & Drug Stores

9.5.3. Online Pharmacies

9.6.    Market Analysis – By Country/ sub-region

9.6.1. Brazil

9.6.2. Mexico

9.6.3. Rest of Latin America

  1. Middle East & Africa Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027

10.1.Key Findings / Summary

10.2.Market Analysis – By Drug Type

10.2.1.    Azoles

10.2.2.    Echinocandins

10.2.3.    Polyenes

10.2.4.    Allylamines

10.3.Market Analysis – By Indication

10.3.1.    Dermatophytosis

10.3.2.    Candidiasis

10.3.3.    Aspergillosis

10.3.4.    Others

10.4.Market Analysis – By Route of Administration

10.4.1.    Oral

10.4.2.    Topical

10.4.3.    Parenteral

10.5.Market Analysis – By Distribution Channel

10.5.1.    Hospitals Pharmacies

10.5.2.    Retail Pharmacies & Drug Stores

10.5.3.    Online Pharmacies

10.6.Market Analysis – By Country/ sub-region

10.6.1.    GCC Countries

10.6.2.    South Africa

10.6.3.    Rest of Middle East & Africa

Continued…

Showing 0 results
Your Answer

Please first to submit.

Get involved

Register

As a member of this site you will be able to receive aggregates news relating only to those categories that are most relevant to you, submit job listings for FREE, post questions in the Q&A, and more.

Register Now

Feature your company

The Feature Your Company listing is your custom-made (by us) profile page that allows you to add any of the following content: text, videos, links, images. The page will also be listed on the Featured Company landing page. Over 560 unique aggregates users visit the site per day! Complete the enquiry form now to contact us.

Contact us

Jobs

Are you looking for an aggregate related job? Click here to see our jobs listing supplied by industry experts United Employment.

See Jobs

Advertise

Reach thousands of budget holders and decision makers by promoting your company on the longest established aggregate website in the US & Canada. Or advertise in our emails which are sent to opted-in subscribers according to their chosen categories. All advertising will display correctly on tablets and mobiles as this site is responsive.